Current therapeutic approaches to primary CNS lymphoma

Area of Science:

• Neuro-oncology
• Hematology
• Clinical Therapeutics

Background:

• Optimal treatment for primary CNS lymphomas is not well-defined.
• Limited prospective studies and randomized trials hinder evidence-based management.
• Retrospective series often suffer from small sample sizes and short follow-up periods.

Purpose of the Study:

• To review current therapeutic strategies for primary CNS lymphomas.
• To provide recommendations for clinical practice based on available evidence.
• To discuss challenges and future research trends in primary CNS lymphoma treatment.

Main Methods:

• Comprehensive literature review of current therapeutic approaches.
• Analysis of commonly used drugs and treatment modalities.
• Evaluation of specific issues like meningeal and intraocular involvement.

Main Results:

• Current management involves chemotherapy, intrathecal chemotherapy, and radiotherapy.
• Salvage therapy plays a role in evaluating novel therapeutic agents.
• Significant challenges remain due to limited high-quality clinical trial data.

Conclusions:

• Further high-quality research, including randomized trials, is crucial for defining optimal treatment.
• Standardized approaches for meningeal and intraocular lymphomas require further investigation.
• Future research should focus on novel drug evaluation and understanding treatment resistance.